Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 115 of the 120 references it cites were found in a registry or an index; 164 of the 191 sources its claims cite were checked for support.

Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy

Open access
Tan, Haowen, Su, Wei, Niu, Zhendong · 2026 · International Journal of Molecular Sciences

Abstract

Sepsis-associated encephalopathy (SAE) is a frequent neurological complication of sepsis, driven by six interconnected pathophysiological components: (1) systemic inflammation-triggered neuroinflammatory cascades, initiated by systemic recognition of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) and propagated by pro-inflammatory mediators; (2) central nervous system (CNS) immune cell-mediated neuroinflammation, wherein microglia, regulatory T cells, and neutrophils dynamically regulate inflammatory progression; (3) blood-brain barrier (BBB) disruption, progressing from functional disturbance to structural damage via tight junction degradation and immune infiltration; (4) multimodal programmed cell death, encompassing autophagy, apoptosis, pyroptosis, and ferroptosis driven by mitochondrial dysfunction; (5) neurotransmitter network imbalance, manifesting as cholinergic deficiency and glutamate excitotoxicity; and (6) gut-brain axis dysregulation, characterized by reduced microbiota-derived metabolites such as butyrate and indolepropionic acid. These components are organized along a core pathological axis comprising four sequential stages: neuroinflammatory storm (encompassing components 1 and 2) → BBB disruption and microcirculatory disturbances (component 3) → multimodal programmed cell death (component 4) → neurotransmitter imbalance (component 5), with the gut-brain axis (component 6) functioning as a bidirectional regulatory node that intersects and modulates all four stages. Mitochondrial dysfunction serves as the central converging node linking these pathological axes. Targeted interventions against neuroinflammation, immune cell modulation, BBB restoration, inhibition of aberrant cell death, neurotransmitter homeostasis, and gut microbiota remodeling hold therapeutic promise. Elucidating the crosstalk among these pathways will accelerate the clinical translation of precision therapies for SAE.

Overview

CoChat Summary

TL;DR

This review synthesizes evidence on sepsis-associated encephalopathy (SAE) pathogenesis into six interconnected components organized along four sequential pathological axes, with mitochondrial dysfunction as the central converging node and the gut–brain axis as a bidirectional regulatory node. It classifies interventions by clinical translation stage and highlights major barriers to clinical translation.

Key findings

  • SAE occurs in more than 50% of hospitalized sepsis patients; characteristic consciousness fluctuations are associated with a three- to fivefold higher risk of death, and in-hospital mortality reaches 45–60% in severe cases.
  • The review proposes six components: neuroinflammatory cascades, CNS immune cell-mediated neuroinflammation, BBB disruption, multimodal programmed cell death (autophagy, apoptosis, pyroptosis, ferroptosis), neurotransmitter network imbalance, and gut–brain axis dysregulation. These are organized as neuroinflammatory storm → BBB disruption and microcirculatory disturbances → multimodal programmed cell death → neurotransmitter imbalance, with the gut–brain axis modulating all four axes and mitochondrial dysfunction as the central converging node.
  • Cited clinical/preclinical data include: SAE patients show 2.3-fold and 1.8-fold increases in peripheral blood S100β and GFAP, respectively, positively correlated with MDA accumulation (r = 0.72), alongside a 40% decrease in SOD activity; SAE model mice show 62–75% decreases in SCFA-producing bacteria and 54–68% reductions in acetate and propionate; propofol combined with dexmedetomidine reduced FTH1 expression by 58% and MDA levels by 41%.
  • Intervention strategies are classified by clinical translation stage—clinically available drugs, preclinical candidates, and potential molecular targets—with examples including NAC, oxytocin, fluoxetine, dexmedetomidine, α7nAChR agonists, FMT, and SCFA/propionate supplementation.

Methods

  • Narrative review with a comprehensive literature search in PubMed, Web of Science, and Embase for studies published between January 2015 and March 2026, combining MeSH terms and free-text keywords; separate searches were conducted for each pathological component (neuroinflammation, BBB disruption, cell death, neurotransmitter imbalance, gut–brain axis).
  • Inclusion criteria: English original research articles, reviews, or clinical studies investigating SAE pathogenesis involving neuroinflammatory cascades, BBB disruption, cell death pathways, or gut–brain axis dysregulation; interventional studies had to report clear mechanisms of action, and reviews were included if they systematically summarized relevant evidence. Exclusion criteria included case reports with fewer than 3 subjects, conference abstracts without full text, and non-peer-reviewed publications.
  • Three-stage selection identified 2500 records, of which 380 underwent full-text review; ultimately 116 references were included in the primary analysis. Data were extracted and synthesized according to four core pathological components, and intervention strategies were critically classified by clinical translation stage.

Limitations

  • The paper states that the proposed integrated pathological axis is established by synthesizing evidence from diverse study designs; most included studies are observational or associative rather than designed to verify causal relationships, so causal interactions among components remain to be validated.
  • The paper states reproducibility concerns and model heterogeneity: LPS injection produces rapid, transient neuroinflammation whereas CLP induces polymicrobial sepsis with more sustained CNS pathology, yielding divergent cytokine profiles and microglial activation kinetics; rodent–human differences in microglial density, BBB tight junction composition, and cholinergic system organization restrict extrapolation. It also notes that SAE lacks standardized diagnostic criteria, animal models use young healthy mice and lack mechanical ventilation, sedation, and polypharmacy, and translational challenges include poor CNS penetration, timing mismatch between preclinical prophylaxis and clinical diagnosis, unvalidated biomarkers (NGAL, S100β, GFAP), and multi-target complexity.
  • Evident from the text: as a narrative review, it does not report a systematic quantitative synthesis or meta-analysis, and no formal risk-of-bias assessment tool is described.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms27125390

Cites

115 of 120 references verified1 citation errors · 4 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Core pathological axis and clinical manifestations of sepsis-associated encephalopathy (SAE). The central symptoms—fluctuating consciousness, cognitive impairment, and neurological deficits—are hypothesized to stem from possible interplay among four pathological axes, which are molecularly dissected into six pathological components in this review: (1) neuroinflammatory cascades and (2) immune cell-mediated regulation collectively constitute Axis 1, the neuroinflammatory storm; (3) BBB disruption and microcirculatory disturbances form Axis 2; (4) multimodal programmed cell death represents Axis 3; (5) neurotransmitter imbalance constitutes Axis 4. The gut–brain axis serves as a key regulatory node (dashed arrows) modulating all four axes. Bidirectional arrows denote plausible positive feedback loops suggested by accumulated evidence between adjacent axes: neuroinflammation exacerbates BBB disruption via cytokine-mediated tight junction degradation, while BBB leakage enables immune infiltration that may amplify neuroinflammation; BBB injury is associated with energy crisis and calcium overload that can trigger programmed cell death, whereas cell death releases DAMPs that further compromise barrier integrity; programmed cell death may disrupts neurotransmitter synthesis and synaptic function, and neurotransmitter imbalance (particularly cholinergic deficiency) likely impairs anti-inflammatory pathways, accelerating glial activation and cell death. Mitochondrial dysfunction serves is proposed as the central converging node linking all four axes. These proposed interactions are based on synthesizing evidence from diverse study designs; causal relationships remain to be validated by future dedicated investigations. Created in BioRender. Retrieved from https://BioRender.com/y7m9d3u on 7 May 2026.
Figure 1 Core pathological axis and clinical manifestations of sepsis-associated encephalopathy (SAE). The central symptoms—fluctuating consciousness, cognitive impairment, and neurological deficits—are hypothesized to stem from possible interplay among four pathological axes, which are molecularly dissected into six pathological components in this review: (1) neuroinflammatory cascades and (2) immune cell-mediated regulation collectively constitute Axis 1, the neuroinflammatory storm; (3) BBB disruption and microcirculatory disturbances form Axis 2; (4) multimodal programmed cell death represents Axis 3; (5) neurotransmitter imbalance constitutes Axis 4. The gut–brain axis serves as a key regulatory node (dashed arrows) modulating all four axes. Bidirectional arrows denote plausible positive feedback loops suggested by accumulated evidence between adjacent axes: neuroinflammation exacerbates BBB disruption via cytokine-mediated tight junction degradation, while BBB leakage enables immune infiltration that may amplify neuroinflammation; BBB injury is associated with energy crisis and calcium overload that can trigger programmed cell death, whereas cell death releases DAMPs that further compromise barrier integrity; programmed cell death may disrupts neurotransmitter synthesis and synaptic function, and neurotransmitter imbalance (particularly cholinergic deficiency) likely impairs anti-inflammatory pathways, accelerating glial activation and cell death. Mitochondrial dysfunction serves is proposed as the central converging node linking all four axes. These proposed interactions are based on synthesizing evidence from diverse study designs; causal relationships remain to be validated by future dedicated investigations. Created in BioRender. Retrieved from https://BioRender.com/y7m9d3u on 7 May 2026.CC BY · PubMed Central
Figure 2 Neuroinflammation mediated by immune cells. Immune cell crosstalk in the regulation of neuroinflammation. Treg: Regulatory T cells; IL: Interleukin; TGF-β: Transforming growth factor beta; LPS: Lipopolysaccharide; INF-γ: Interferon gamma; NFKB: Nuclear factor kappa-light-chain-enhancer of activated B cells; STAT: Signal Transducer and Activator of Transcription; ROS: Reactive Oxygen Species; TNF-α: Tumor necrosis factor alpha; Th1: Type 1 T helper cell; Th17: Type 17 T helper cell; M1: M1 macrophage; M2: M2 macrophage; NETs: Neutrophil Extracellular Traps. Created in BioRender. Retrieved from https://BioRender.com/wfjuk3n on 7 May 2026.
Figure 2 Neuroinflammation mediated by immune cells. Immune cell crosstalk in the regulation of neuroinflammation. Treg: Regulatory T cells; IL: Interleukin; TGF-β: Transforming growth factor beta; LPS: Lipopolysaccharide; INF-γ: Interferon gamma; NFKB: Nuclear factor kappa-light-chain-enhancer of activated B cells; STAT: Signal Transducer and Activator of Transcription; ROS: Reactive Oxygen Species; TNF-α: Tumor necrosis factor alpha; Th1: Type 1 T helper cell; Th17: Type 17 T helper cell; M1: M1 macrophage; M2: M2 macrophage; NETs: Neutrophil Extracellular Traps. Created in BioRender. Retrieved from https://BioRender.com/wfjuk3n on 7 May 2026.CC BY · PubMed Central
Figure 3 Canonical pyroptosis pathway mediated by the NLRP3 inflammasome. Pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) activate the NLRP3 inflammasome, which recruits and cleaves pro-caspase-1 into active caspase-1. Active caspase-1 executes two critical functions: (1) it cleaves gasdermin D (GSDMD) into its N-terminal fragment (N-GSDMD), which oligomerizes and forms pores in the plasma membrane, leading to cell swelling, membrane rupture, and the release of cytoplasmic contents (including LDH and HMGB1); (2) it cleaves pro-IL-1β and pro-IL-18 into their mature forms, which are released through GSDMD pores to amplify local and systemic inflammatory responses. This positive feedback loop perpetuates neuroinflammation and exacerbates blood–brain barrier disruption in SAE. Abbreviations: IL, interleukin; GSDMD, gasdermin D; N-GSDMD, N-terminal fragment of GSDMD; NLRP3, NLR family pyrin domain containing 3; LDH, lactate dehydrogenase; HMGB1, high mobility group box 1. Created in BioRender. Retrieved from https://BioRender.com/r8y030v on 7 May 2026.
Figure 3 Canonical pyroptosis pathway mediated by the NLRP3 inflammasome. Pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) activate the NLRP3 inflammasome, which recruits and cleaves pro-caspase-1 into active caspase-1. Active caspase-1 executes two critical functions: (1) it cleaves gasdermin D (GSDMD) into its N-terminal fragment (N-GSDMD), which oligomerizes and forms pores in the plasma membrane, leading to cell swelling, membrane rupture, and the release of cytoplasmic contents (including LDH and HMGB1); (2) it cleaves pro-IL-1β and pro-IL-18 into their mature forms, which are released through GSDMD pores to amplify local and systemic inflammatory responses. This positive feedback loop perpetuates neuroinflammation and exacerbates blood–brain barrier disruption in SAE. Abbreviations: IL, interleukin; GSDMD, gasdermin D; N-GSDMD, N-terminal fragment of GSDMD; NLRP3, NLR family pyrin domain containing 3; LDH, lactate dehydrogenase; HMGB1, high mobility group box 1. Created in BioRender. Retrieved from https://BioRender.com/r8y030v on 7 May 2026.CC BY · PubMed Central
Figure 4 Canonical ferroptosis pathway involving iron metabolism and lipid peroxidation. The ferroptosis cascade proceeds through three sequential stages: (1) Iron accumulation: Transferrin (Tf) binds ferric iron (Fe3+) and delivers it to the transferrin receptor (TfR); the complex is internalized into endosomes, where STEAP3 reduces Fe3+ to ferrous iron (Fe2+), which is then exported to the cytosol via DMT1. (2) Lipid peroxidation: Cytosolic Fe2+ drives the Fenton reaction with hydrogen peroxide (H2O2) to generate highly reactive hydroxyl radicals (HO•), which attack polyunsaturated fatty acids (PUFAs) within membrane phospholipids (PL-PUFA), generating toxic lipid hydroperoxides (PL-PUFA-OOH). (3) Failed antioxidant defense and membrane rupture: Under normal conditions, glutathione peroxidase 4 (GPX4) converts PL-PUFA-OOH to non-toxic alcohols (PL-PUFA-OH), thereby inhibiting ferroptosis. In SAE, GPX4 activity is suppressed due to glutathione depletion and SLC7A11/xCT downregulation, leading to unchecked lipid peroxidation, membrane rupture, and cell death. Abbreviations: Tf, transferrin; TfR, transferrin receptor; Fe2+, ferrous iron; Fe3+, ferric iron; DMT1, divalent metal transporter 1; HO•, hydroxyl radical; PL, phospholipid; PUFA, polyunsaturated fatty acid; GPX4, glutathione peroxidase 4; STEAP3, six-transmembrane epithelial antigen of prostate 3. Created in BioRender. Retrieved from https://BioRender.com/926q8g1 on 7 May 2026.
Figure 4 Canonical ferroptosis pathway involving iron metabolism and lipid peroxidation. The ferroptosis cascade proceeds through three sequential stages: (1) Iron accumulation: Transferrin (Tf) binds ferric iron (Fe3+) and delivers it to the transferrin receptor (TfR); the complex is internalized into endosomes, where STEAP3 reduces Fe3+ to ferrous iron (Fe2+), which is then exported to the cytosol via DMT1. (2) Lipid peroxidation: Cytosolic Fe2+ drives the Fenton reaction with hydrogen peroxide (H2O2) to generate highly reactive hydroxyl radicals (HO•), which attack polyunsaturated fatty acids (PUFAs) within membrane phospholipids (PL-PUFA), generating toxic lipid hydroperoxides (PL-PUFA-OOH). (3) Failed antioxidant defense and membrane rupture: Under normal conditions, glutathione peroxidase 4 (GPX4) converts PL-PUFA-OOH to non-toxic alcohols (PL-PUFA-OH), thereby inhibiting ferroptosis. In SAE, GPX4 activity is suppressed due to glutathione depletion and SLC7A11/xCT downregulation, leading to unchecked lipid peroxidation, membrane rupture, and cell death. Abbreviations: Tf, transferrin; TfR, transferrin receptor; Fe2+, ferrous iron; Fe3+, ferric iron; DMT1, divalent metal transporter 1; HO•, hydroxyl radical; PL, phospholipid; PUFA, polyunsaturated fatty acid; GPX4, glutathione peroxidase 4; STEAP3, six-transmembrane epithelial antigen of prostate 3. Created in BioRender. Retrieved from https://BioRender.com/926q8g1 on 7 May 2026.CC BY · PubMed Central

Verification

Claims the paper makes

122 Valid · 16 Not valid · 15 Not checked · 41 Own results and interpretations

138 more claims · 100 with their cited sources checked

Create a free account to see all 194 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 47
  • Probably not a substantial claim. 7
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 116 references

Metadata

Authors
Tan, H., Su, W., & Niu, Z.
Affiliations
Sichuan University (CN)
Corresponding author
Niu, Zhendong
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2026-06-15
Volume
27
Issue
12
Pages
5390
ISSN
1422-0067 (ISSN-L)
OpenAlex
W7164863602
Cited by
1
References
116
Citations by year
2026: 1
FWCI
1.15
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Ministry of Science and Technology of the People’s Republic of China (STI2030-Major Projects2021ZD0201900)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
sepsis-associated encephalopathy, neuroinflammation, pathogen-associated molecular patterns, damage-associated molecular patterns, microglia, regulatory T cells, neutrophils, blood-brain barrier disruption, tight junctions, programmed cell death, autophagy, apoptosis, pyroptosis, ferroptosis, mitochondrial dysfunction, glutamate excitotoxicity, cholinergic deficit, gut-brain axis, gut microbiota metabolites, butyrate, indolepropionic acid, microcirculatory disturbances
MeSH terms
Neuroinflammatory Diseases, Animals, Blood-Brain Barrier, Humans, Mitochondria, Sepsis, Sepsis-Associated Encephalopathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy. https://app.cochat.ai/papers/10.3390/ijms27125390
The paper
Tan, H., Su, W., & Niu, Z. (2026). Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27125390

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.